We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
Cap. Flow
-$982M
Cap. Flow %
-2.08%
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$250M
2
SBUX icon
Starbucks
SBUX
+$152M
3
CERN
Cerner Corp
CERN
+$122M
4
CL icon
Colgate-Palmolive
CL
+$87.1M
5
PG icon
Procter & Gamble
PG
+$77.4M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$456M
2
CSCO icon
Cisco
CSCO
+$392M
3
ADI icon
Analog Devices
ADI
+$151M
4
UPS icon
United Parcel Service
UPS
+$148M
5
VAR
Varian Medical Systems, Inc.
VAR
+$89.7M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Consumer Discretionary 15.92%
3 Financials 12.69%
4 Healthcare 12.47%
5 Communication Services 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRA icon
851
BlackRock Floating Rate Income Strategies Fund
FRA
$385M
$0 ﹤0.01%
6
-1,496
-100% -$21.4K
FSTR icon
852
Foster
FSTR
$432M
– –
-53
Closed -$1K
GDDY icon
853
GoDaddy
GDDY
$11.5B
– –
-590
Closed -$30K
GE icon
854
GE Aerospace
GE
$384B
– –
-8,501
Closed -$711K
GILD icon
855
Gilead Sciences
GILD
$165B
– –
-161
Closed -$12K
HAE icon
856
Haemonetics
HAE
$4B
– –
-710
Closed -$41K
HLF icon
857
Herbalife
HLF
$1.29B
– –
-814
Closed -$28K
INTC icon
858
Intel
INTC
$513B
– –
-1,578
Closed -$73K
IQV icon
859
IQVIA
IQV
$39.3B
– –
-257
Closed -$25K
ITT icon
860
ITT
ITT
$19.1B
– –
-530
Closed -$28K
IWM icon
861
iShares Russell 2000 ETF
IWM
$83B
– –
-2,103
Closed -$321K
IWM icon
862
PUT
iShares Russell 2000 ETF
IWM
$83B
– –
-292,600
Closed -$44.6M
K
863
DELISTED
Kellanova
K
– –
-2,437
Closed -$156K
LAMR icon
864
Lamar Advertising Co
LAMR
$16.3B
– –
-171,692
Closed -$12.7M
LOW icon
865
Lowe's Companies
LOW
$125B
– –
-14,275
Closed -$1.33M
LRCX icon
866
Lam Research
LRCX
$390B
– –
-4,140
Closed -$76K
MU icon
867
Micron Technology
MU
$991B
– –
-660
Closed -$27K
NHTC icon
868
Natural Health Trends
NHTC
$14.8M
– –
-87
Closed -$1K
NPK icon
869
National Presto Industries
NPK
$989M
– –
-45
Closed -$4K
NUS icon
870
Nu Skin
NUS
$267M
– –
-432
Closed -$29K
OMCL icon
871
Omnicell
OMCL
$1.68B
– –
-534
Closed -$26K
ON icon
872
ON Semiconductor
ON
$31.6B
– –
-1,422
Closed -$30K
PAG icon
873
Penske Automotive Group
PAG
$14.2B
– –
-25,776
Closed -$1.23M
RITM icon
874
Rithm Capital
RITM
$5.69B
– –
-18,475
Closed -$330K
SCHL icon
875
Scholastic
SCHL
$792M
– –
-400
Closed -$16K
33 34
35
36 37

Similar funds

CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Loomis, Sayles & Company's Q1 2018 Portfolio in Review

As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
  • Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
  • Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
  • Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
  • Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
  • Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
  • Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.

Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.